LFCR
Lifecore Biomedical Inc.
4.50$
+0.3%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
Lifecore Biomedical Inc. (LFCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Operating Cash Flow" came in at 13 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 22 | 29 | 20 | 16 | -17 | 16 | -24 | -23 | 0.3 | -0.2 | 13 | |
| 7.1 | 9.4 | 11 | 12 | 15 | 19 | 20 | 18 | 18 | 8.0 | 8.0 | 6.8 | |
| 1.6 | 3.5 | 4.0 | 4.4 | 3.6 | 0.0 | 3.4 | 2.6 | 2.6 | 6.2 | 10 | 6.2 | |
| – | – | – | – | 2.0 | 30 | 19 | 62 | 32 | – | – | – | |
| 3.3 | -2.5 | 0.6 | -10 | -1.2 | -28 | 9.8 | -6.6 | -3.1 | -3.7 | -4.7 | -2.3 | |
| 18 | 41 | 23 | 34 | 45 | 27 | 25 | 28 | 30 | 18 | 13 | 6.3 | |
| -34 | -42 | -25 | -36 | -97 | -24 | -12 | 82 | 80 | -18 | -6.4 | -1.6 | |
| – | – | – | – | 0.7 | 0.2 | – | – | 0.3 | 3.1 | – | – | |
| -0.3 | – | -0.4 | -1.5 | -0.7 | -0.2 | -0.4 | – | -0.8 | -0.2 | – | -1.9 | |
| – | – | – | – | 80 | 42 | 7.5 | -55 | 19 | 2.2 | -16 | – | |
| 8.2 | 16 | -8.8 | 13 | 79 | 40 | -3.4 | -57 | -57 | 7.5 | 6.4 | -1.1 | |
| -0.1 | -4.2 | -4.5 | -2.5 | -1.8 | -0.9 | 0.7 | 0.3 | 0.3 | -11 | -0.2 | -0.2 | |
| 8.6 | -19 | 6.7 | -14 | -29 | -44 | -8.8 | -53 | -53 | -18 | -14 | 6.2 |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.